SCHEMBL9998138

SCHEMBL9998138

CC(=O)OC(OC(C)=O)/C(=C/c1ccc(C(C)(C)C)cc1)Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
TSHR P16473 1/20 0.42
LMNA P02545 3/20 0.42
TRPV1 Q8NER1 2/20 0.41
RAB9A P51151 3/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
NPC1 O15118 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
MCL1 Q07820 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
ESRRG P62508 1/20 0.39
MAPT P10636 3/20 0.38
GAA P10253 2/20 0.38
POLB P06746 1/20 0.38
CYP2C19 P33261 1/20 0.38
CYP1A2 P05177 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MITF O75030 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998140 1.00 ALDH1A1 (0.44) ALDH1A1TSHRLMNATRPV1RAB9A
SCHEMBL9998025 0.88 CYP3A4 (0.50) ALDH1A1TSHRRAB9AKMT2AMEN1
SCHEMBL9998023 0.88 CYP3A4 (0.50) ALDH1A1TSHRRAB9AKMT2AMEN1
SCHEMBL9998345 0.86 CYP26A1 (0.41) ALDH1A1TSHRTRPV1CYP3A4CYP2C9
SCHEMBL9998346 0.86 CYP26A1 (0.41) ALDH1A1TSHRTRPV1CYP3A4CYP2C9
SCHEMBL9997838 0.85 TSHR (0.45) ALDH1A1TSHRLMNARAB9AKMT2A
SCHEMBL9997840 0.85 TSHR (0.45) ALDH1A1TSHRLMNARAB9AKMT2A
SCHEMBL9997558 0.84 TSHR (0.44) ALDH1A1TSHRLMNARAB9AKMT2A
SCHEMBL9998091 0.84 ALDH1A1 (0.46) ALDH1A1TSHRLMNARAB9AKMT2A
SCHEMBL9998089 0.84 ALDH1A1 (0.46) ALDH1A1TSHRLMNARAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 ALDH1A1 160/4885TSHR 621/4885LMNA 3752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.